141 related articles for article (PubMed ID: 8312687)
1. Indomethacin decreases viscosity of gallbladder bile in patients with cholesterol gallstone disease.
von Ritter C; Niemeyer A; Lange V; Möhrle W; Richter WO; von Meyer L; Brandl H; del Pozo R; Jüngst D
Clin Investig; 1993 Nov; 71(11):928-32. PubMed ID: 8312687
[TBL] [Abstract][Full Text] [Related]
2. Decreased protein concentration and improved metastability of bile induced by ursodeoxycholate.
Chijiwa K; Hirota I; Noshiro H
Gastroenterol Jpn; 1992 Feb; 27(1):88-94. PubMed ID: 1555751
[TBL] [Abstract][Full Text] [Related]
3. Total protein content of human gallbladder bile: relation to cholesterol gallstone disease and effects of treatment with bile acids and aspirin.
Sahlin S
Eur J Surg; 1996 Jun; 162(6):463-9. PubMed ID: 8817223
[TBL] [Abstract][Full Text] [Related]
4. Effect of the type of dietary fat on biliary lipid composition and bile lithogenicity in humans with cholesterol gallstone disease.
Yago MD; González V; Serrano P; Calpena R; Martínez MA; Martínez-Victoria E; Mañas M
Nutrition; 2005 Mar; 21(3):339-47. PubMed ID: 15797676
[TBL] [Abstract][Full Text] [Related]
5. Increased biliary protein precedes gallstone formation.
Moser AJ; Abedin MZ; Roslyn JJ
Dig Dis Sci; 1994 Jun; 39(6):1313-20. PubMed ID: 8200266
[TBL] [Abstract][Full Text] [Related]
6. Ursodeoxycholic acid decreases viscosity and sedimentable fractions of gallbladder bile in patients with cholesterol gallstones.
Fischer S; Müller I; Zündt BZ; Jüngst C; Meyer G; Jüngst D
Eur J Gastroenterol Hepatol; 2004 Mar; 16(3):305-11. PubMed ID: 15195895
[TBL] [Abstract][Full Text] [Related]
7. Biliary lipid composition in patients with cholesterol and pigment gallstones and gallstone-free subjects: deoxycholic acid does not contribute to formation of cholesterol gallstones.
Gustafsson U; Sahlin S; Einarsson C
Eur J Clin Invest; 2000 Dec; 30(12):1099-106. PubMed ID: 11122325
[TBL] [Abstract][Full Text] [Related]
8. Biliary alpha 1-acid glycoprotein concentrations in gallstone-free controls and in patients with multiple or solitary cholesterol gallstones.
Nuutinen H; Abei M; Schwarzendrube J; Ginanni Corradini S; Walsh RM; Kawczak P; Holzbach RT
Dig Dis Sci; 1995 Aug; 40(8):1786-91. PubMed ID: 7648981
[TBL] [Abstract][Full Text] [Related]
9. Does lipid infusion affect bile composition in humans?
Rubin M; Pakula R; Moser A; Halpern Z; Shimonov M; Lichtenberg D
Isr J Med Sci; 1996 Dec; 32(12):1308-13. PubMed ID: 9007178
[TBL] [Abstract][Full Text] [Related]
10. The effect of vitamin C in high doses on plasma and biliary lipid composition in patients with cholesterol gallstones: prolongation of the nucleation time.
Gustafsson U; Wang FH; Axelson M; Kallner A; Sahlin S; Einarsson K
Eur J Clin Invest; 1997 May; 27(5):387-91. PubMed ID: 9179545
[TBL] [Abstract][Full Text] [Related]
11. Molecular composition of biliary phosphatidylcholines, as related to cholesterol saturation, transport and nucleation in human gallbladder bile.
Angelico M; Ginanni Corradini S; Masella R; Alvaro D; Cantafora A; Capocaccia L
J Hepatol; 1992 May; 15(1-2):59-66. PubMed ID: 1506657
[TBL] [Abstract][Full Text] [Related]
12. Hepatic bile versus gallbladder bile: a comparison of protein and lipid concentration and composition in cholesterol gallstone patients.
Keulemans YC; Mok KS; de Wit LT; Gouma DJ; Groen AK
Hepatology; 1998 Jul; 28(1):11-6. PubMed ID: 9657090
[TBL] [Abstract][Full Text] [Related]
13. The effects of the 3-hydroxy, 3-methylglutaryl coenzyme A reductase inhibitor pravastatin on bile composition and nucleation of cholesterol crystals in cholesterol gallstone disease.
Smit JW; van Erpecum KJ; Renooij W; Stolk MF; Edgar P; Doornewaard H; Vanberge-Henegouwen GP
Hepatology; 1995 Jun; 21(6):1523-9. PubMed ID: 7768495
[TBL] [Abstract][Full Text] [Related]
14. Bile lithogenicity and gallbladder emptying in patients with microlithiasis: effect of bile acid therapy.
Sharma BC; Agarwal DK; Dhiman RK; Baijal SS; Choudhuri G; Saraswat VA
Gastroenterology; 1998 Jul; 115(1):124-8. PubMed ID: 9649467
[TBL] [Abstract][Full Text] [Related]
15. Relation of gallbladder motility to viscosity and composition of gallbladder bile in patients with cholesterol gallstones.
Gründel D; Jüngst C; Straub G; Althaus R; Schneider B; Spelsberg FW; Hüttl TP; del Pozo R; Jüngst D; Neubrand M
Digestion; 2009; 79(4):229-34. PubMed ID: 19390195
[TBL] [Abstract][Full Text] [Related]
16. Deoxycholic acid treatment in patients with cholesterol gallstones: failure to detect a suppression of cholesterol 7alpha-hydroxylase activity.
Hillebrant C; Nyberg B; Angelin B; Axelson M; Björkhem I; Rudling M; Einarsson C
J Intern Med; 1999 Oct; 246(4):399-407. PubMed ID: 10583711
[TBL] [Abstract][Full Text] [Related]
17. Effects of long-term ursodeoxycholate administration on expression levels of secretory low-molecular-weight phospholipases A2 and mucin genes in gallbladders and biliary composition in patients with multiple cholesterol stones.
Kano M; Shoda J; Irimura T; Ueda T; Iwasaki R; Urasaki T; Kawauchi Y; Asano T; Matsuzaki Y; Tanaka N
Hepatology; 1998 Aug; 28(2):302-13. PubMed ID: 9695991
[TBL] [Abstract][Full Text] [Related]
18. Nature and composition of biliary sludge.
Lee SP; Nicholls JF
Gastroenterology; 1986 Mar; 90(3):677-86. PubMed ID: 3943697
[TBL] [Abstract][Full Text] [Related]
19. Correlation between biliary alpha 1-acid glycoprotein concentration and cholesterol crystal nucleation time in gallstone disease.
Nuutinen H; Ginanni Corradini S; Jüngst D; Lange V; Abei M; Schwarzendrube J; Williams C; Holzbach RT
Dig Dis Sci; 1995 Jun; 40(6):1174-8. PubMed ID: 7781430
[TBL] [Abstract][Full Text] [Related]
20. Measurement of apolipoprotein A1 in cholesterol gallstones and gallbladder bile of patients with gallstones.
Hasegawa T; Makino I
J Gastroenterol; 1995 Feb; 30(1):96-102. PubMed ID: 7719423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
